Valion Bio(VBIO)
$0.50-0.03 (-4.92%)
VBIO
Valion Bio financials statements
$0.50
At close:-0.03 (-4.92%)
Want to see VBIO full AI Analyst Report?
Valion Bio (VBIO) Income Statement
175 Followers
Valion Bio Income Statement
Last quarter (Q2 2026), Valion Bio's total revenue was $146.00K, an increase of 148.34% from the same quarter last year. In Q2, Valion Bio's net income was $-2.60M. See Valion Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 24 | Dec 23 | Mar 23 |
|---|---|---|---|---|---|
| $ 0.00 | $ 1.18M | $ 0.00 | $ 1.84M | $ 1.26M | |
| $ 0.00 | $ 287.00K | $ -352.00K | $ 299.00K | $ -46.00K | |
| $ 7.90M | $ 8.53M | $ 4.06M | $ 10.40M | $ 5.59M | |
| Depreciation and Amortization | $ 5.00K | $ 182.00K | $ 352.00K | $ 174.00K | $ 24.00K |
| $ -7.84M | $ -8.06M | $ -4.06M | $ -9.92M | $ -5.61M | |
| $ -7.90M | $ -8.24M | $ -4.42M | $ -10.10M | $ -5.63M | |
| $ -95.00K | $ 1.00K | $ -54.00K | $ 2.00K | $ -2.86M | |
| $ -7.99M | $ -8.24M | $ -4.47M | $ -10.10M | $ -8.49M | |
| $ -8.88M | $ -8.24M | $ -5.66M | $ -10.10M | $ -8.49M | |
| Per Share Metrics | |||||
| Basic EPS | $ -7.84 | $ -176.80 | $ -19.68 | $ -1768.00 | $ -4133.60 |
| Diluted EPS | $ -7.84 | $ -176.80 | $ -19.68 | $ -1768.00 | $ -4133.60 |
| Weighted Average Shares Outstanding | 1.16M | 46.65K | 287.37K | 5.69K | 2.05K |
| Weighted Average Shares Outstanding (Diluted) | 1.16M | 46.65K | 287.37K | 5.69K | 2.05K |
Currency in USD
